Our findings indicate that PUS7 functions upstream of NETs formation, and that pharmacological degradation of NETs via DNase I abolishes the tumour‐promoting effects of PUS7 in orthotopic mouse models, thereby validating the functional significance of this pathway. The gene discussed is DNASE1; the disease is neoplasm.